Tuesday, March 24, 2009

Toyama Chemical and Eisai Decide to Conduct Additional Study

March 24, 2009--Toyama Chemical Co., Ltd. and Eisai Co., Ltd. announced today that the companies have decided to withdraw temporarily the New Drug Application (NDA) of anti-rheumatic drug T-614 (generic name: iguratimod), which have been developed jointly by the two companies in Japan.

the details can be read here.

No comments: